GlaxoSmithKline Inc.
Registration:
28
of
67
(2015-05-06
to
2015-08-18)
Senior Officers whose lobbying activities represent less than 20% of their Duties
-
Rav Kumar,
Vice President Regulatory Affairs and Pharma Development
-
Paul Lirette,
President and Chief Executive Officer
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
No lobbyists added
- Date Modified: